A bevy of positive headlines didn't launch stocks to the moon, but they did at least manage to end losing streaks in a couple of the major indices.
On the COVID-19 vaccine front, Pfizer (PFE, +3.9%) unveiled a timetable in which it could apply for FDA emergency-use approval by late November. While that's slower than the Election Day timeline touted by President Donald Trump, it still would qualify as extremely rapid development of a successful vaccine.
Economic data provided some hope, too. U.S. retail sales rose 1.9% month-over-month, well above economists' estimates.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"Despite unemployment benefits expiring for millions of Americans, today's retail sales figure shows us there is still some gas in the tank for the consumer," says Charlie Ripley, senior investment strategist for Allianz Investment Management, though he added it's not all positive. "The overall level of retail sales is well above pre-pandemic levels, however, when you dig deeper into the underlying data, businesses that have been hit the hardest continue to struggle."
Also, a preliminary University of Michigan consumer sentiment reading edged higher, mostly on optimism about conditions improving in 2021.
The Dow Jones Industrial Average didn't gain much, but the 0.4% improvement to 28,606 was enough to snap a three-day losing streak.
Other action in the stock market today:
- The S&P 500 also snapped a three-day skid, albeit with a whisper-thin half-point gain to 3,483.
- The Nasdaq Composite closed 0.4% lower to 11,671.
- The Russell 2000 declined 0.3% to 1,633.
The Case for the Occasional Moonshot
Does it feel like your portfolio is in a rut? It's not just you.
The Pros' Picks: 9 Stocks to Sell Now
Stocks are broadly up for 2020 and successfully broke out of bear-market territory in record speed, but the indices are effectively flat since the start of September, mired in political and medical uncertainty.
But remember: That doesn't mean all stocks are flat.
Most portfolios can do with a small allocation toward aggressive plays that shoot higher even when the indices are sluggish. Sports betting stocks, for instance, could be an intriguing play -- they face the risk of more COVID-related shutdowns, but if not, they could leverage record dollars being gambled across several states.
If you're more passionate about politics than sports, you could always invest in stocks that analysts believe will jump depending on who is elected president this November -- here, we look at 10 stocks that would succeed under Joe Biden, and 10 different picks for another four years of President Donald Trump.
And it's hard to beat small-cap technology for pure growth potential. Yes, we mentioned yesterday that Goldman is cooling on the sector in the short-term, but a group of smaller plays are well-positioned in trending technologies for several years' worth of outperformance. Here, we look at seven small-cap tech stocks that have powerful upside potential that's difficult to ignore.
-
Stocks Struggle Ahead of November Jobs Report: Stock Market TodayOracle and Broadcom continued to fall, while market participants looked ahead to Tuesday's jobs report.
-
7 Dr. Seuss Quotes Retirees Should Live ByYou're off to great places! Why Dr. Seuss is the retirement guru you didn't know you needed.
-
Fed's Rate Cuts Could Have Impacts You Might Not AnticipateUnderstanding how lower interest rates could impact your wallet can help you determine the right financial moves to make.
-
If You'd Put $1,000 Into Coca-Cola Stock 20 Years Ago, Here's What You'd Have TodayEven with its reliable dividend growth and generous stock buybacks, Coca-Cola has underperformed the broad market in the long term.
-
If You Put $1,000 into Qualcomm Stock 20 Years Ago, Here's What You Would Have TodayQualcomm stock has been a big disappointment for truly long-term investors.
-
If You'd Put $1,000 Into Home Depot Stock 20 Years Ago, Here's What You'd Have TodayHome Depot stock has been a buy-and-hold banger for truly long-term investors.
-
S&P 500 Sees New Highs on Shutdown Day: Stock Market TodayMost of its components were in the red, but the S&P 500 Index still managed to hit a new intraday all-time high.
-
If You'd Put $1,000 Into Bank of America Stock 20 Years Ago, Here's What You'd Have TodayBank of America stock has been a massive buy-and-hold bust.
-
If You'd Put $1,000 Into Oracle Stock 20 Years Ago, Here's What You'd Have TodayORCL Oracle stock has been an outstanding buy-and-hold bet for decades.
-
If You'd Put $1,000 Into Sherwin-Williams Stock 20 Years Ago, Here's What You'd Have TodaySherwin-Williams stock has clobbered the broader market by a wide margin for a long time.
-
If You'd Put $1,000 Into UnitedHealth Group Stock 20 Years Ago, Here's What You'd Have TodayUNH stock was a massive market beater for ages — until it wasn't.
